Cargando…
Increased Lifetime Risk of ESRD in Familial IgA Nephropathy
INTRODUCTION: Familial IgA nephropathy (IgAN) has been widely reported. However, its clinicohistologic characteristics and long-term prognosis are not clear. METHODS: A total of 348 familial IgAN cases from 167 independent families were recruited and their clinicohistologic characteristics as well a...
Autores principales: | Shi, Manman, Yu, Shuwen, Ouyang, Yan, Jin, Yuanmeng, Chen, Zijin, Wei, Wenjie, Fang, Zhengying, Du, Wen, Wang, Zhaohui, Weng, Qinjie, Tong, Jun, Pan, Xiaoxia, Wang, Weiming, Krzysztof, Kiryluk, Chen, Nan, Xie, Jingyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783566/ https://www.ncbi.nlm.nih.gov/pubmed/33426388 http://dx.doi.org/10.1016/j.ekir.2020.10.015 |
Ejemplares similares
-
A validation study of crescents in predicting ESRD in patients with IgA nephropathy
por: Zhang, Xiaoyan, et al.
Publicado: (2018) -
A Validation Study Comparing Risk Prediction Models of IgA Nephropathy
por: Ouyang, Yan, et al.
Publicado: (2021) -
A Rare Genetic Defect of MBL2 Increased the Risk for Progression of IgA Nephropathy
por: Ouyang, Yan, et al.
Publicado: (2019) -
Oral glucocorticoids with intravenous cyclophosphamide or oral glucocorticoids alone in the treatment of IgA nephropathy present with nephrotic syndrome and mesangioproliferative glomerulonephritis
por: Du, Wen, et al.
Publicado: (2023) -
Predicting Progression of IgA Nephropathy: New Clinical Progression Risk Score
por: Xie, Jingyuan, et al.
Publicado: (2012)